SCHEMBL30140443

SCHEMBL30140443

Fc1c(Nc2ncnc3ccc(O[C@H]4CCNC4)nc23)ccc(OCC2CCOCC2)c1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 11/20 0.41
KDR P35968 9/20 0.39
FLT1 P17948 6/20 0.39
FGFR1 P11362 3/20 0.39
FLT4 P35916 3/20 0.39
EPHA2 P29317 7/20 0.39
EPHB4 P54760 6/20 0.39
MKNK2 Q9HBH9 2/20 0.38
ERBB2 P04626 4/20 0.35
GAK O14976 1/20 0.35
EPHB6 O15197 1/20 0.35
RIPK2 O43353 1/20 0.35
STK10 O94804 1/20 0.35
MAP4K4 O95819 1/20 0.35
ABL1 P00519 1/20 0.35
LCK P06239 1/20 0.35
YES1 P07947 1/20 0.35
LYN P07948 1/20 0.35
RET P07949 1/20 0.35
HCK P08631 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30140346 0.95 EGFR (0.46) EGFRKDRFLT1FGFR1FLT4
SCHEMBL30140131 0.95 EGFR (0.46) EGFRKDRFLT1FGFR1FLT4
SCHEMBL30140165 0.95 EGFR (0.46) EGFRKDRFLT1FGFR1FLT4
SCHEMBL30140062 0.91 EGFR (0.42) EGFRKDRFLT1FGFR1FLT4
SCHEMBL30140289 0.90 EPHA2 (0.43) KDRFLT1EPHA2EPHB4MKNK2
SCHEMBL30140291 0.90 EPHA2 (0.43) KDRFLT1EPHA2EPHB4MKNK2
SCHEMBL30140277 0.89 KDR (0.39) EGFRKDRFLT1FGFR1FLT4
SCHEMBL30140295 0.89 EGFR (0.41) EGFRKDRFLT1FGFR1FLT4
SCHEMBL30140390 0.88 EPHA2 (0.41) EGFRKDRFLT1EPHA2EPHB4
SCHEMBL30140098 0.88 EPHA2 (0.41) EGFRKDRFLT1EPHA2EPHB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022266426-A1 6-(HETEROCYCLOALKYL-OXY)-QUINAZOLINE DERIVATIVES AND USES THEREOF BLACK DIAMOND THERAPEUTICS, INC. (US) 2022-12-22 WO disclosed